BPC-157 Dosage for Tissue Repair Stages: A Weekly Protocol

July 14, 2026
4 min read
Contents

    BPC-157 Dosage for Tissue Repair Stages: A Weekly Protocol

    BPC-157 dosage for tissue repair stages typically starts at 250-500 mcg per day, split into one or two injections, and can be adjusted based on the phase of healing. When combined with TB-500, a common weekly protocol uses 2.5 mg of TB-500 twice weekly alongside daily BPC-157, with a TB-500 dosage calculator helping to tailor amounts by body weight. This article provides a stage-by-stage breakdown of the tissue repair process and how to dose these peptides for optimal recovery.

    Understanding the Tissue Repair Stages

    Tissue repair unfolds in three overlapping stages: inflammation, proliferation, and remodeling. The inflammation stage begins immediately after injury, lasting a few days, as immune cells clear debris and release growth factors. Next, the proliferation stage builds new tissue with collagen and blood vessels over several weeks. Finally, the remodeling stage strengthens and reorganizes that tissue for months. BPC-157 and TB-500 work synergistically to accelerate each phase, but timing and dosage matter.

    BPC-157 Dosage by Tissue Repair Stage

    BPC-157, a gastric pentadecapeptide, promotes angiogenesis and cell migration. For acute injuries, a standard BPC-157 dosage is 250-500 mcg daily, injected near the injury site if possible. During the inflammation stage, a higher dose of 500 mcg twice daily can reduce swelling and pain. As you enter the proliferation stage, continue with 250-500 mcg daily to support collagen synthesis. In the remodeling stage, a maintenance dose of 250 mcg daily helps ensure proper tissue alignment. Always start low and adjust based on response.

    Weekly Protocol with TB-500 Calculator

    TB-500, a synthetic fragment of thymosin beta-4, is typically dosed at 2.5 mg twice weekly for most adults. A TB-500 dosage calculator can refine this: multiply your body weight in kilograms by 0.07 mg for a weekly total, then split into two doses. For example, a 70 kg person would use about 5 mg per week, or 2.5 mg per injection. Combine this with daily BPC-157 for a powerful tissue repair stack. Inject TB-500 subcutaneously, rotating sites, and time it with BPC-157 for convenience.

    Sample Weekly Protocol

    • Monday: BPC-157 500 mcg morning, TB-500 2.5 mg evening.
    • Tuesday: BPC-157 500 mcg morning.
    • Wednesday: BPC-157 500 mcg morning.
    • Thursday: BPC-157 500 mcg morning, TB-500 2.5 mg evening.
    • Friday: BPC-157 500 mcg morning.
    • Saturday: BPC-157 500 mcg morning.
    • Sunday: BPC-157 500 mcg morning.

    This protocol provides continuous BPC-157 support with twice-weekly TB-500 boosts. Adjust BPC-157 dosage down to 250 mcg if side effects occur.

    How BPC-157 and TB-500 Work Together

    BPC-157 and TB-500 complement each other by targeting different aspects of healing. BPC-157 accelerates angiogenesis and modulates nitric oxide, while TB-500 upregulates actin and cell migration. Together, they enhance the tissue repair process more than either alone. For chronic injuries, extending the protocol to 6-8 weeks is common, with a 2-week break before repeating. Always consult a healthcare provider before starting any peptide regimen.

    Using a TB-500 Dosage Calculator

    A TB-500 dosage calculator simplifies dosing by accounting for weight and injury severity. The standard formula is 0.05-0.1 mg per kg per week. For a 60 kg individual, that's 3-6 mg weekly, split into two doses. For acute injuries, use the higher end; for maintenance, use the lower end. Combine this with BPC-157 at 250-500 mcg daily. Track your progress and adjust as needed. Remember, these peptides are for research purposes only.

    Safety and Side Effects

    BPC-157 and TB-500 are generally well-tolerated, with few reported side effects. Some users experience mild nausea or injection site reactions. To minimize risks, use sterile water for reconstitution and proper injection techniques. Avoid use if pregnant or nursing. Long-term effects are not fully studied, so cycle responsibly. For more on peptide regulations, see recent changes to Health Canada's personal import rules for peptides.

    Optimizing the Tissue Repair Process

    Beyond peptides, support the tissue repair process with adequate protein intake, vitamin C, and sleep. Avoid anti-inflammatory drugs during the early stages, as they can blunt healing. BPC-157 and TB-500 work best when combined with physical therapy and gradual loading. Monitor your recovery milestones and adjust the protocol if progress stalls. For a deeper dive into peptide performance, explore how Medicare coverage of GLP-1s is impacting performance peptides.

    Frequently Asked Questions

    Can I use BPC-157 orally instead of injecting?

    Oral BPC-157 is available but may be less effective for localized injuries. Injections provide higher bioavailability near the site. For systemic healing, oral forms can work, but dosing is less precise. Stick to injectable BPC-157 for tissue repair stages if possible.

    How long does it take to see results?

    Many users report reduced pain within days, but full tissue repair takes weeks to months. Acute injuries may improve in 2-4 weeks, while chronic issues need 6-8 weeks. Consistency with the BPC-157 dosage and TB-500 schedule is key.

    Is a prescription required for these peptides?

    In many regions, BPC-157 and TB-500 are sold as research chemicals, not for human use. Regulations vary, so check local laws. For context on peptide legality, read about AOD-9604 legal status in Quebec and Canada.

    Conclusion

    Tailoring BPC-157 dosage to tissue repair stages and combining it with a calculated TB-500 protocol can significantly enhance recovery. Start with 250-500 mcg of BPC-157 daily and 2.5 mg of TB-500 twice weekly, adjusting with a TB-500 dosage calculator based on weight. Always prioritize safety and consult a professional. For more on peptide research, see what the ADA 2026 discussions mean for Quebec athletes using peptides.

    For research and educational purposes only.